SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.680+7.0%2:28 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (4307)10/10/1999 12:45:00 PM
From: DanZ   of 10293
 
<They'd better have more convincing clinical results to back their claims than the people at Quigley did.>

I agree, and the first study probably wouldn't convince some pharmaceutical companies to get behind Zicam. GumTech characterizes the first study as testing a product whereas they characterize the second study as testing science. This may have contributed to the decline in the stock after the news of Zicam was released in January. I don't see the same circumstance with the second clinical studies. If they come back as conclusive as the first study (p < 0.001) or anything better than p < 0.05, I think the medical community will be convinced and that a rally in the stock will be sustained. The only flaw that I can find in the first study is that they don't know if the subjects were actually infected with a rhinovirus. Still, the results of that study are too compelling to discount completely and I am confident that it will be published soon.

I really don't care for the feud that has developed between me and others here. I will make an effort in the future to avoid confrontations, and in return, only ask that Bill makes an effort to avoid his daily jabs at GumTech. If he is mature and isn't playing a game with me, he will honor this request.

Thanks,
Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News